Announcements Trials

Browse Landscape

Phase

Phase 3 11 Phase 2 8 Phase 1/2 3 Phase NA 1 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Extranodal NK-T-Cell 2 Biliary Tract Neoplasms 2 Thoracic Neoplasms 1 Squamous Non-small-cell Lung Cancer 1 Oligospermia 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Lung Diseases 1 Fibrosis 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Adenocarcinoma Pancreas 1 Adenocarcinoma 1

Interventions

toripalimab 1 Tobacco Use Cessation Devices 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Gene Expression Profiling 1 Gemcitabine 1 Early Intervention, Educational 1 Counseling 1 Cisplatin 1 Carboplatin 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Nasopharyngeal Neoplasms × Gemcitabine × Clear all

NCT06457503 2026-04-06

TRANSPARENT

Coherus Oncology, Inc.

Phase 4 Recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡